'Peg ifn' diaporamas de présentation

891 views • 74 slides

How to Optimize Treatment of non G1 Patients

Luncheons PHC Paris January 31, 2012. How to Optimize Treatment of non G1 Patients. Alessandra Mangia S. Giovanni Rotondo ITALY. March 14, 2011. 49 years old man, BMI: 28 HCV diagnosed in 1998 - previous iv drug and alcohol user - genotype 3, HCVRNA:410.000 IU/ml

503 views • 50 slides

Michael P. Manns Markus Cornberg Medizinische Hochschule Hannover Dept. of Gastroenterology, Hepatology and Endocrinolog

PUBLIC HEALTH CHALLENGES FOR CONTROLLING HCV INFECTION. Hepatitis C: Therapeutic options. Michael P. Manns Markus Cornberg Medizinische Hochschule Hannover Dept. of Gastroenterology, Hepatology and Endocrinology Germany. VHPB Meeting, Ferney Voltaire, France May 13 - 14, 2002.

723 views • 47 slides

Michael P. Manns Markus Cornberg Medizinische Hochschule Hannover

PUBLIC HEALTH CHALLENGES FOR CONTROLLING HCV INFECTION. Hepatitis C: Therapeutic options. Michael P. Manns Markus Cornberg Medizinische Hochschule Hannover Dept. of Gastroenterology, Hepatology and Endocrinology Germany. VHPB Meeting, Ferney Voltaire, France May 13 - 14, 2002.

573 views • 47 slides

HBV Factors and Clinical Outcomes M Omata

HBV Factors and Clinical Outcomes M Omata. Genotypes in China and Japan. West Asia. North East Asia. Miyakawa Y et al. Intervirology 2003. North East Asia. B and C. D. West Asia. Any Difference Between B and C. Born Infected. Natural Course HBV Infection. HBeAg-positive. ALT.

489 views • 39 slides

501 views • 37 slides

Hepatitis B: predictors and endpoints revisited?

418 views • 33 slides

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline. HCV WORLD CAB ? FEBRUARY 2014 BANGKOK, THAILAND. When to Treat HCV. HCV Direct-Acting Antivirals ( DAAs ) in development. Know your epidemic: what matters HCV treatment overview : now & in the near future Strategies for scaling up.

547 views • 31 slides

Protease and Polymerase Inhibitors for the Treatment of Hepatitis C

310 views • 30 slides

Standard Interferon vs. Pegylated Interferon

309 views • 30 slides

3rd Paris Hepatitis Conference: Morning Session on HBeAg-Neg CHB

3rd Paris Hepatitis Conference: Morning Session on HBeAg-Neg CHB. WHY DO I TREAT MY PATIENTS WITH PEGYLATED INTERFERON?. Bob Perrillo Baylor University Medical Center Dallas, TX USA. Problems Confronting Clinician with HBeAg Negative Hepatitis B.

293 views • 29 slides

HCV in the HIV infected Patient

386 views • 26 slides

Hepatitis C Nonresponders

306 views • 24 slides

36 year old HCV+ woman, Risk factor: occasional IVDU 15 years ago

Case study. 36 year old HCV+ woman, Risk factor: occasional IVDU 15 years ago First treatment with PEG-IFN/RBV in 2002 only qualitative PCR available : positive at W12 and W24 Treatment stopped after 24 weeks Weight: 65 kg, BMI: 23 No comorbidity, no medications

328 views • 23 slides

HIV / HCV co-infection

HIV / HCV co-infection. Through the eyes of a co-infected hemophiliac . I.D. History-The HCV Diagnosis. More bad news delivered on the heels of an HIV diagnosis. I attend funerals for others I knew through the hemophilia clinic, lost to HIV.

356 views • 19 slides

Adjuvant Therapy for Melanoma What is the role of PegIFN in relation to HDIFN?

Adjuvant Therapy for Melanoma What is the role of PegIFN in relation to HDIFN?. John M. Kirkwood, MD Professor of Medicine, Dermatology and Translational Science University of Pittsburgh School of Medicine &Cancer Institute Melanoma Committee, Eastern Cooperative Oncology Group

370 views • 19 slides

254 views • 9 slides

QUEST-2 Study : SMV + PEG-IFN + RBV for genotype 1

255 views • 8 slides

Hepatitis C Virus (HCV) Coinfection: New Drugs, New Strategies

Hepatitis C Virus (HCV) Coinfection: New Drugs, New Strategies. Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco. From MG Peters, MD, at Los Angeles, CA: April 22, 2013, IAS-USA. .

217 views • 8 slides

MALACHITE study : OBV/PTV/r + DSV + RBV versus telaprevir + PEG-IFN + RBV in genotype 1

90 views • 8 slides